LINKÖPING, Sweden–(BUSINESS WIRE)–Regulatory News:
“The unique low-radiation mammography technology that we have developed
and introduced on the market will receive broad international
distribution and benefit many women. In addition to the capital gain,
the transaction with Philips will contribute favorably to the Group’s
operating profit this financial year”